Molecular biology of Burkitt's lymphoma
The diagnostic category of Burkitt's lymphoma encompasses a closely related group of
aggressive B-cell tumors that includes sporadic, endemic, and human immunodeficiency …
aggressive B-cell tumors that includes sporadic, endemic, and human immunodeficiency …
B cell chronic lymphocytic leukemia: lessons learned from studies of the B cell antigen receptor
N Chiorazzi, M Ferrarini - Annual review of immunology, 2003 - annualreviews.org
B cell chronic lymphocytic leukemia (B-CLL) is an accumulative disease of slowly
proliferating CD5+ B lymphocytes that develops in the aging population. Whereas some …
proliferating CD5+ B lymphocytes that develops in the aging population. Whereas some …
Clinical impact of the differentiation profile assessed by immunophenotyping in patients with diffuse large B-cell lymphoma
L Colomo, A López-Guillermo… - Blood, The Journal …, 2003 - ashpublications.org
To analyze the relationship between immunophenotyping profile and main
clinicopathological features and outcome in diffuse large B-cell lymphoma (DLBCL), we …
clinicopathological features and outcome in diffuse large B-cell lymphoma (DLBCL), we …
Whole-genome sequencing reveals activation-induced cytidine deaminase signatures during indolent chronic lymphocytic leukaemia evolution
Patients with chromosome 13q deletion or normal cytogenetics represent the majority of
chronic lymphocytic leukaemia (CLL) cases, yet have relatively few driver mutations. To …
chronic lymphocytic leukaemia (CLL) cases, yet have relatively few driver mutations. To …
Deregulated BCL6 expression recapitulates the pathogenesis of human diffuse large B cell lymphomas in mice
Diffuse large B cell lymphomas (DLBCL) derive from germinal center (GC) B cells and
display chromosomal alterations deregulating the expression of BCL6, a transcriptional …
display chromosomal alterations deregulating the expression of BCL6, a transcriptional …
Mutations of the BCL6 proto-oncogene disrupt its negative autoregulation in diffuse large B-cell lymphoma
L Pasqualucci, A Migliazza, K Basso… - Blood, The Journal …, 2003 - ashpublications.org
The BCL6 proto-oncogene encodes a transcriptional repressor whose expression is
deregulated by chromosomal translocations in approximately 40% of diffuse large B-cell …
deregulated by chromosomal translocations in approximately 40% of diffuse large B-cell …
The molecular pathogenesis of primary mediastinal large B-cell lymphoma
C Steidl, RD Gascoyne - Blood, The Journal of the American …, 2011 - ashpublications.org
Primary mediastinal large B-cell lymphoma (PMBCL) is a recognized non-Hodgkin
lymphoma entity with unique pathologic, clinical, and molecular characteristics distinct from …
lymphoma entity with unique pathologic, clinical, and molecular characteristics distinct from …
Clinical significance of CD38 expression in chronic lymphocytic leukemia
G Del Poeta, L Maurillo, A Venditti… - Blood, The Journal …, 2001 - ashpublications.org
B-cell chronic lymphocytic leukemia (B-CLL) follows heterogeneous clinical courses, and
several biological parameters need to be added to the current clinical staging systems to …
several biological parameters need to be added to the current clinical staging systems to …
Prognostic biomarkers in diffuse large B-cell lymphoma
IS Lossos, D Morgensztern - Journal of clinical oncology, 2006 - ascopubs.org
Diffuse large B-cell lymphoma (DLBCL) is the most common type of non-Hodgkin's
lymphoma. Although it represents a curable disease, less than half of the patients are cured …
lymphoma. Although it represents a curable disease, less than half of the patients are cured …
Distinctive patterns of BCL6 molecular alterations and their functional consequences in different subgroups of diffuse large B-cell lymphoma
Gene expression profiling of diffuse large B-cell lymphoma (DLBCL) has revealed
biologically and prognostically distinct subgroups: germinal center B-cell-like (GCB) …
biologically and prognostically distinct subgroups: germinal center B-cell-like (GCB) …